|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.88 CAD | +27.54% |
|
+27.54% | +60.00% |
Eastwood Bio-Medical Canada Inc. reported earnings results for the full year ended October 31, 2023. For the full year, the company reported sales was CAD 0.749651 million compared to CAD 1.16 million a year ago. Revenue was CAD 0.867936 million compared to CAD 1.3 million a year ago.
Net loss was CAD 0.546598 million compared to CAD 0.149879 million a year ago. Basic loss per share from continuing operations was CAD 0.01.
| 1st Jan change | Capi. | |
|---|---|---|
| +60.00% | 44.28M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
EASTWOOD BIO-MEDICAL CANADA INC. 
